跳至主要内容
临床试验/CTRI/2017/09/009700
CTRI/2017/09/009700已完成未知

A Registry to describe clinical experience with Thymoglobuline® used as induction immunosuppression in patients undergoing renal transplantation - RISE

Sanofi Synthelabo India Private Limited0 个研究点目标入组 356 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
356

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patient >= 18 years of age
  • 2. Patient is a candidate for renal transplant
  • 3. The investigator decides to use Thymoglobuline as induction therapy independent of this registry
  • 4. signed informed consent
  • Note-Renal transplant could be a first transplant or a repeat transplant

排除标准

  • 1. Active, acute or chronic infections
  • 2. Hypersensitivity to rabbit proteins or any of the excipients
  • 3. Pregnancy or lactation
  • 4. Concurrent participation (or participation in the previous 12 weeks) in any another clinical trial
  • 5.Any contraindication to use of Thymoglobuline
  • 6. Special transplants such as combined kidney and other organ like pancreas transplants, ABO incompatible transplants, and transplant requiring desensitization

研究者

发起方
Sanofi Synthelabo India Private Limited

相似试验